Peripheral blood progenitor cell mobilisation in patients with multiple myeloma following oral idarubicin and dexamethasone (Z-Dex) induction therapy. [electronic resource]
Producer: 19980211Description: S35-40 p. digitalISSN:- 0887-6924
- Administration, Oral
- Adult
- Aged
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cisplatin -- therapeutic use
- Colony-Forming Units Assay
- Cyclophosphamide -- therapeutic use
- Cytarabine -- therapeutic use
- Dexamethasone -- administration & dosage
- Dose-Response Relationship, Drug
- Etoposide -- therapeutic use
- Female
- Flow Cytometry
- Hematopoietic Stem Cell Mobilization -- methods
- Humans
- Idarubicin -- administration & dosage
- Male
- Mesna -- therapeutic use
- Middle Aged
- Multiple Myeloma -- drug therapy
- Remission Induction
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.